Диссертация (1174253), страница 23
Текст из файла (страница 23)
– P.401-410.100.Kronish, I. Metaanalysis: impact of drug class on adherence toantihypertensives. / I. Kronish, M. Woodward, Z. Sergie et al. // Circulation. –2011. - №123. – P. 1611–1621.101.Kumagai, N. Improving drug adherence using fixed combinations causedbeneficial treatment outcomes and decreased health-care costs in patients withhypertension. / N. Kumagai, K. Onishi, K. Hoshino et al. // Clinical andExperimental Hypertension. -2013. - №35. – P.
355–360.102.Lalic, J. Medication Adherence in Outpatients with Arterial Hypertension. /J. Lalic, R. Velickovic Radovanovic, B. Mitic et al. // Scientific Journal of theFaculty of Medicine in Nis. – 2013. - №30 (4). - P. 209–218.103.Landolfo, M. Hyperuricaemia and vascular risk: the debate continues. / M.Landolfo, C. Borghi // Current opinion in cardiology. – 2019. - №34 (4). –P. 399405.104.Lefort, M. Sex differences in adherence to antihypertensive treatment inpatients aged above 55: The French League Against Hypertension Survey(FLAHS).
/ M. Lefort, L. Neufcourt, B. Pannier et al. // Journal of ClinicalHypertension (Greenwich). – 2018. - №20 (10). - P. 1496-1503.105.Lim, S. A comparative risk assessment of burden of disease and injuryattributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a144systematic analysis for the Global Burden of Disease Study 2010. / S. Lim, T.Vos, A. Flaxman et al. // Lancet. - 2012.
- №380. - P. 2224–2260.106.Mancia, G. ESH/ESC practice guidelines for the management of arterialhypertension./ G. Mancia, R. Fagard, K. Narkiewicz et al. // Blood Pressure. –2014. - №23. – P. 3–16., Williams, B. ESC Scientific Document Group; 2018ESC/ESH Guidelines for the management of arterial hypertension. / B. Williams,G. Mancia, W. Spiering et al. // European Heart Journal. – 2018. - №39 (33). – P.3021–3104.107.Mancia, G. Long-term prognostic value of blood pressure variability in thegeneral population: results of the Pressioni Arteriose Monitorate e LoroAssociazoni Study. / G.
Mancia, M. Bombelli, R. Facchetti et al. // Hypertension.- 2007. - №49. – P. 1265-1270.108.Mandviwala, T. Obesity and Cardiovascular Disease: a Risk Factor or aRisk Marker? / T. Mandviwala, U. Khalid, A. Deswal // Current atherosclerosisreports. – 2016. - № 18. [Электронный ресурс] – Режим доступа:https://link.springer.com/article/10.1007/s11883-016-0575-4.109.Mallat, S.G. Free versus Fixed Combination Antihypertensive Therapy forEssential Arterial Hypertension: A Systematic Review and Meta-Analysis.
/ S. G.Mallat, B.Y. Tanios, H.S. Itani et al. // PLOS ONE. 2016. [Электронныйресурс] – Режим доступа: https://doi.org/10.1371/journal.pone.0161285110.Меna, L.J. The behalf of the International Database on Ambulatory BloodPressure in Relation to Cardiovascular Outcomes (IDACO) Investigators HowMany Measurements Are Needed to Estimate Blood Pressure Variability WithoutLoss of Prognostic Information? / L.J. Меna, G.E. Maestre, T.W.
Hansen et al. //Journal of Hypertension. – 2014. - №27 (1). – P. 46-55.111.Mills, K.T. Global disparities of hypertension prevalence and control: asystematic analysis of populationbased studies from 90 countries. / K.T. Mills,J.D. Bundy, T.N. Kelly et al. // Circulation.
– 2016. - №134. – С. 441–450.145112.Morisky, D. E. Concurrent and predictive validity of a self-reportedmeasure of medication adherence. / D. E. Morisky, L. W. Green, D.M. Levine //Medical Care. – 1986. - №24 (1). – С. 67-74.113.Mourad,J.Bloodpressure-loweringefficacyandsafetyofperindopril/indapamide/amlodipine single-pill combination in patients withuncontrolled essential hypertension: a multicenter, randomized, double-blind,controlled trial. / J.
Mourad, C. Amodeo, M. de Champvallins et al. // Journal ofHypertension. – 2017. - №35 (7). – P. 1481-1495.114.Musini, V. Blood pressure-lowering efficacy of monotherapy with thiazidediuretics for primary hypertension. / V. Musini, M. Nazer, K. Bassett, J. Wright //Cochrane Database of Systematic Reviews. 2014. [Электронный ресурс] –Режим доступа: https://doi.org/10.1002/14651858.CD003824.pub2115.Nedogoda,S.Single-PillCombinationofPerindopril/Indapamide/Amlodipine in Patients with Uncontrolled Hypertension:A Randomized Controlled Trial. / S. Nedogoda, V.
Stojanov // Cardiology andTherapy. – 2017. – V. 6. – I. 1. – P. 91–104.116.Nichols, M. European сardiovascular disease statistics 2012. / M. Nichols,N. Townsend, P. Scarborough et al. – Brussels: European Society of Cardiology;2012. – P.125.117.O’Brien,.uropean Society of Hypertension position paper onambulatory blood pressure monitoring./ . O’Brien , G. Parati, G. Stergiou et al.// Journal of hypertension.- 2013.- V. 31. – I. 9. – P. 1731-1768.118.O’Brien,. The role of t enty-four-hour ambulatory blood pressuremeasurement in clinical practice.
/ E. O'Brien, J. Cox, K. O'Malley.// Journal ofHypertension. – 1991. - №9 (8). – P. 63-65.119.Os, I. Effects of losartan in women with hypertension and left ventricularhypertrophy: results from the Losartan Intervention for Endpoint Reduction inHypertension Study. / I. Os, V. Franco, S.E. Kjeldsen et al. // Hypertension. –2008. - №51.
- P. 1103–1108.146120.Pall,D.TripleCombinationTherapyinHypertension:TheAntihypertensive Efficacy of treatment with Perindopril, Amlodipine, andIndapamide SR. / D. Pall, L. Szanto, Z. Szabo. // Clinical Drug Investigation. –2014. - №34 (10). – P. 701-708.121.Parati, G. Impact of antihypertensive combination and monotreatments onblood pressure variability: assessment by old and new indices. Data from a largeambulatory blood pressure monitoring database. / G. Parati, E.
Dolan, H.Schumacher. // Journal of Hypertension. – 2014. - V. 32. - I. 6. - P. 1326-1333.122.Parati, G. European Society of Hypertension Working Group on BloodPressure Monitoring and Cardiovascular Variability. European Society ofHypertension practice guidelines for ambulatory blood pressure monitoring. / G.Parati, G. Stergiou , E.
O'Brien et al.// Journal of Hypertension. - 2014. – №32.–P. 1359–1366.123.Pimenta, E. Hypertension in women. / E. Pimenta // HypertensionResearch. – 2012. - №35. – P. 148-152.124.PROGRESS Collaborative Study Group. Randomised trial of perindoprilbased blood pressure-lowering regimen among 6108 individuals with previousstroke or transient ischaemic attack. / PROGRESS Collaborative Study Group. //Lancet.
– 2001. - №358 (9287). – P. 1033-1041.125.Qvarnström, M. Persistence to antihypertensive drug classes: A cohortstudy using the Swedish Primary Care Cardiovascular Database (SPCCD). / M.Qvarnström, T. Kahan, H. Kieler et al. // Medicine (Baltimore). -2016. - №95(40).[Электронныйресурс]–Режимдоступа:https://insights.ovid.com/crossref?an=00005792-201610040-00030.126.Raymundo, A.
Adherence to anti-hypertensive treatment within a chronicdisease management program: A longitudinal, retrospective study. / A.Raymundo, A. Pierin // Revista da Escola de Enfermagem da USP. - 2014. - V.48. – I. 5. – P. 809-817.147127.Reckelhoff, J. Gender differences in hypertension. / J. Reckelhoff //Current Opinion in Nephrology and Hypertension.
– 2018. – V. 27. - I. 3. – P.176-181.128.Regitz-Zagrosek, V. Gender in cardiovascular diseases: impact on clinicalmanifestations, management, and outcomes. / V.Regitz-Zagrosek, S. OerteltPrigione, E. Prescott et al. // European Heart Journal. – 2016. - №37 (1). – P. 24–34.129.Rock, K. Uric acid as a danger signal in gout and its comorbidities. / K.Rock, H.
Kataoka, J. Lai // Nature reviews. Rheumatology. -2013. –V. 1. - I. 9. P. 13-23.130.Roger, V.L. Heart disease and stroke statistics—2011 update: a report fromthe American Heart Association. / V.L. Roger, A.S Go, D.M. Lloyd-Jones et al. //Circulation. - 2011. - №123. – P. 18–209.131.Rosano, G. Gender differences in the effect of cardiovascular drugs: aposition document of the Working Group on Pharmacology and Drug Therapy ofthe ESC.
/ G. Rosano, B. Lewis, S. Agewall et al. // European Heart Journal. –2015. - №36. - P. 2677–2680.132.Roush, G. Head-to-head comparisons of hydrochlorothiazide withindapamide and chlorthalidone: antihypertensive and metabolic effects. / G.Roush, M. Ernst, J. Kostis et al. // Hypertension. - 2015. - №65. – P. 1041–1046.133.Rydberg, D.M. Sex differences in spontaneous reports on adverse drugevents for common antihypertensive drugs. / D.M. Rydberg, S.
Mejyr, D. Loikaset al. // European journal of clinical pharmacology. – 2018. –V. 74 – I. 9. - P.1165-1173.134.Sabate E. Adherence to Long-Term Therapies: Evidence for Action. / /[edited by E. Sabate]. World Health Organization. //Geneva: World HealthOrganization, 2003. – P. 194.135.Samson, S. Metabolic syndrome. / S. Samson, A. Garber // Endocrinologyand metabolism clinics of North America.
-2014. - №43 (1). - P. 1-23.148136.Scherer, P.E. Adipose tissue: from lipid storage compartment to endocrineorgan. / P. E. Scherer // Diabetes. – 2006. - №55. P. 1537–1545.137.Scott,P.E.ParticipationofWomeninClinical Trials SupportingFDA Approval of Cardiovascular Drugs. / P.E. Scott, E.F. Unger, M.R. Jenkinset al. Journal of the American College of Cardiology. – 2018. – 8. – V. 71. – I.18. – P. 1960-1969.138.Shah, R. Epidemiology report: trends in sex-specific cerebrovasculardiseasemortality in Europe based on WHO mortality data. / R.
Shah, E. Wilkins,M. Nichols et al. // European Heart. – 2019. - №40. – P. 755–764.139.Scheen, A. Which place for thiazide and thiazide-like diuretics in patientswith type 2 diabetes. / A. Scheen, J. Krzesinski // Revue medicale de Liege. –2018. - №73(4). – P. 176-182.140.Shin,S.Effectofantihypertensivemedicationadherenceonhospitalization for cardiovascular disease and mortality in hypertensive patients. /S. Shin, H.
Song, S. Oh et al. // Hypertension Research. – 2013. - №36 (11). – P.1000-1005.141.Soldin, O. Sex differences in pharmacokinetics and pharmacodynamics. /O. Soldin, D. Mattison // Clinical Pharmacokinetics. – 2009. - №48. - P. 143–157.142.Song, S. Gender Differences in the Association between Dietary Patternand the Incidence of Hypertensionin Middle-Aged and Older Adults. / S. Song, J.Kim, J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
